Trials / Conditions / Inclusion Body Myositis (IBM)
Inclusion Body Myositis (IBM)
4 registered clinical trials studyying Inclusion Body Myositis (IBM).
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Exercise as Treatment for Patients With Inclusion Body Myositis NCT06644482 | Oslo University Hospital | N/A |
| Active Not Recruiting | Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body Myositis NCT06450886 | Abcuro, Inc. | Phase 2 / Phase 3 |
| Completed | Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis NCT02481453 | Institut National de la Santé Et de la Recherche Médicale, France | Phase 2 / Phase 3 |
| Unknown | Natalizumab in Inclusion Body Myositis (IBM) NCT02483845 | Phoenix Neurological Associates, LTD | Phase 1 |